Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | BMY | AMGN | GILD | GSK |
| Company | Ascendis Pharma ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 144.53 | 48.45 | 266.83 | 67.80 | 40.02 |
| High | 148.10 | 48.60 | 267.51 | 67.89 | 40.23 |
| Low | 141.05 | 48.24 | 263.81 | 67.18 | 39.72 |
| Last | 141.50 | 48.26 | 265.64 | 67.31 | 39.95 |
| Change | -3.73 | -0.25 | +0.13 | -0.44 | -0.55 |
| % Change | -2.57% | -0.52% | +0.05% | -0.65% | -1.36% |
| Volume | 367,400 | 11,931,102 | 2,017,500 | 4,974,900 | 2,422,733 |
| 20-Day Average Volume | 316,675 | 11,536,980 | 2,269,115 | 6,427,060 | 2,848,490 |
| Previous Close | 145.23 | 48.51 | 265.51 | 67.75 | 40.50 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 147.95 | 51.36 | 273.86 | 70.93 | 41.63 |
| 20-Day Raw Stochastic | 2.85% | 2.20% | 7.39% | 1.83% | 6.17% |
| 20-Day Relative Strength | 44.38% | 36.07% | 38.83% | 30.61% | 36.08% |
| Weighted Alpha | +60.49 | -30.24 | +5.85 | -23.45 | +10.47 |
| Today's Opinion | 40% Buy | 56% Sell | 40% Sell | 100% Sell | 40% Buy |
| Previous Opinion | 48% Buy | 56% Sell | 40% Sell | 100% Sell | 40% Buy |
| Last Month's Opinion | 88% Buy | 8% Sell | 8% Sell | 72% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.92% since 04/09/24 | -6.47% since 04/09/24 | -1.75% since 04/09/24 | -3.76% since 04/09/24 | -2.27% since 04/09/24 |
| Low | 141.05 on 04/16/24 | 48.12 on 04/15/24 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 39.72 on 04/16/24 |
| High | 156.84 on 04/10/24 | 51.28 on 04/10/24 | 273.00 on 04/11/24 | 69.76 on 04/10/24 | 41.25 on 04/11/24 |
| 1-Month | |||||
| %Chg | -4.84% since 03/15/24 | -7.80% since 03/15/24 | -1.20% since 03/15/24 | -8.66% since 03/15/24 | -5.31% since 03/15/24 |
| Low | 141.05 on 04/16/24 | 48.12 on 04/15/24 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 39.72 on 04/16/24 |
| High | 156.84 on 04/10/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 43.45 on 03/25/24 |
| 3-Month | |||||
| %Chg | +5.99% since 01/16/24 | -3.48% since 01/16/24 | -12.47% since 01/16/24 | -21.72% since 01/16/24 | +0.18% since 01/16/24 |
| Low | 127.95 on 01/31/24 | 47.58 on 02/06/24 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 38.56 on 01/25/24 |
| High | 161.00 on 02/26/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 43.84 on 03/07/24 |
| 6-Month | |||||
| %Chg | +50.39% since 10/16/23 | -15.59% since 10/16/23 | -7.40% since 10/16/23 | -15.01% since 10/16/23 | +9.21% since 10/16/23 |
| Low | 85.29 on 10/23/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 67.18 on 04/16/24 | 33.67 on 11/02/23 |
| High | 161.00 on 02/26/24 | 57.65 on 10/17/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 43.84 on 03/07/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,455,870 | 98,318,080 | 142,291,856 | 84,353,968 | 83,933,824 |
| Shares Outstanding, K | 58,224 | 2,026,759 | 535,919 | 1,245,077 | 2,072,440 |
| Annual Sales | 288,670,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 37,725,000,000 |
| Annual Net Income | -521,070,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 6,129,940,000 |
| Last Quarter Sales | 148,660,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 9,980,060,000 |
| Last Quarter Net Income | -93,040,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 433,200,000 |
| 60-Month Beta | 0.50 | 0.39 | 0.58 | 0.19 | 0.64 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.66 on 02/07/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 0.72 on 01/31/24 |
| Latest Earnings Date | 04/25/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | 0.397 on 02/22/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | 02/22/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.44 | 14.33 | 10.13 | 10.56 |